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1. Butan-1-ol solubilizes that portion of rat liver mitochondrial aspartate amino-
transferase (EC 2.6.1.1) that cannot be solubilized by ultrasonics and other treat-
ments. 2. A difference in electrophoretic mobilities, chromatographic behaviour and
solubility characteristics between the enzymes solubilized by ultrasonic treatment
and by butan-l-ol was observed, suggesting the occurrence of two forms of this
enzyme in rat liver mitochondria. 3. Half the aspartate aminotransferase activity
of rat kidney homogenate was present in a high-speed supernatant fraction, the
remainder being in the mitochondria. 4. A considerable increase in aspartate
aminotransferase activity was observed when kidney mitochondrial suspensions
were treated with ultrasonics or detergents. 5. All the activity after maximum
activation was recoverable in the supernatant after centrifugation at 105 OOOg for
1 hr. 6. The electrophoretic mobility of the kidney mitochondrial enzyme was
cathodic and that of the supernatant enzyme anodic. 7. Cortisone administration
increased the activities of both mitochondrial and supernatant aspartate amino-
transferases of liver, but only that of the supernatant enzyme of kidney.
Recent studies have established the presence of
two different forms of GOT* in rat liver (Boyd,
1961; Eichel & Bukovsky, 1961; Katunama,
Matsuzawa & Huzino, 1962; Morino, Kagamiyama
& Wada, 1964). They differ in electrophoretic
mobility (Boyd, 1961; Eichel & Bukovsky, 1961),
Km (Katunama et al. 1962) and immunological
characteristics (Morino et al. 1964). One form is
localized in mitochondria and the other is present
in the supernatant fraction (Boyd, 1961; Eichel &
Bukovsky, 1961). Attempts to solubilize the mito-
chondrial enzyme by treatment with detergents,
ultrasonic treatment, disintegration in a Waring
Blendor or freezing-and-thawing resulted in a
severalfold increase in activity (Bhargava &
Sreenivasan, 1965, 1966a,b). The increased activity
was associated with enzyme that had been solubil-
ized, but the original activity remained pellet-bound
(Bhargava & Sreenivasan, 1966b) and further
treatments of the pellet did not result in activation
or solubilization of GOT. Recently Boyd (1966)
reported quantitative solubilization of the mito-
chondrial enzyme by treatment with butan-l-ol.
It was therefore decided to test whether butan-1-ol
could solubilize the pellet-bound enzyme and, if so,
whether pellet-bound enzyme solubilized by butan-
* Abbreviation: GOT, aspartate aminotransferase (L-
aspartate-2-oxoglutarate aminotransferase, EC 2.6.1.1).
1 -ol is the same as or different from the enzyme
solubilized by other treatments.
A study of GOT in kidney was undertaken to
examine the possibility of tissue-specific differences
with respect to the occurrence of GOT. The effect
of cortisone administration on mitochondrial and
supernatant GOT enzymes of rat liver and kidney
was also investigated, since there are conflicting
reports (Sergio & Cordoba, 1963; Kenney, 1962;
Goldstein, Stella & Knox, 1962; Sheid & Roth,
1965; Barnaberi & Serni, 1962) with regard to the
induction of liver GOT enzymes by cortisone
administration and none for the kidney. It was also
decided to test whether there are any tissue-
specific differences in induction of the two forms of
GOT brought by cortisone.
EXPERIMENTAL
Preparation of subcellular fractions, treatment of mito-
chondria, determination of GOT activity, paper electrophoresis
and butan-l-ol treatment. Wistar-strain rats maintained on
laboratory stock diet were used throughout. Kidneys were
perfused via the dorsal aorta with chilled 0.9% NaCl. They
were then cut into smallpieces with scissors and homogenized
in chilled 0-25 m-sucrose in a Teflon-glass homogenizer. The
preparation ofsubcellular fractions (at 2-4°) was carried out
as described by Schneider (1948). Isolation of liver mito-
chondria, determination of GOT activity, treatment with
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detergents, ultrasonic treatment and paper electrophoresis
were done as described in previous papers (Bhargava &
Sreenivasan, 1965, 1966a,b). GOT activity units are
expressed as ,umoles of oxaloacetate formed during incuba-
tion at 370 for 10min. and are given as means+ S.E.M. of
four independent observations. Butan-l-ol treatment of
the pellet obtained after centrifugation of treated mito-
chondrial suspension and of intact mitochondria was
carried out as described by Boyd (1966).
Column chromatography. Column chromatography on a
30 cm. x 1 cm. column of CM-cellulose was carried out after
activation and equilibration with 0-1M-sodium phosphate
buffer, pH 6-8, with a gradient of 0-1-1 M-NaCl for elution;
3 ml. fractions were collected.
Cortisone administration. This was done intraperi-
toneally by injecting cortisone acetate (4mg.f100g. body
wt.) in 0.9% NaCl. Rats were killed after 4-6 hr.
RESULTS AND DISCUSSION
Solubilization and electrophoretic mobility of pellet-
bound GOT. The mitochondrial GOT that cannot
be solubilized by ultrasonics and other treatments
(Bhargava & Sreenivasan, 1966b) and remains in
the pellet on centrifugation at 105 OOOg for 1 hr. was
solubilized by treatment with butan-1-ol (Table 1).
The pellet enzyme was almost completely solubilized
when the final concentration of butan-l-ol was 20%
(v/v) (Table 1).
The paper-electrophoretic mobility of mito-
chondrial GOT solubilized by ultrasonic treatment
(GOT1) was slower than that of pellet-bound GOT
solubilized by butan-l-ol (GOT2) (Fig. 1).
When the intact mitochondria were treated
with butan-l-ol no increase in GOT activity was
observed, though the solubilization achieved was
similar to that ofpellet-bound GOT with butan-1 -ol.
This suggests that butan-l-ol may be inactivating
Table 1. Effect of butan-l-ol concentration on the
solubilization of pellet-bound GOT of liver mito-
chondria
A mitochondrial pellet, obtained by centrifugation of
ultrasonically treated mitochondrial suspension, was
treated with increasing concentrations of butan-1-ol after
suspension in 0-25M-sucrose, and the GOT activities were
determined in whole suspensions and the sediments and
supernatants obtained by centrifugation at 1050OOg for
1 hr. For further details see the text.
GOT activity (units
Concn. of
butan- 1 -ol
(v/v)
0
5
10
15
20
In pellet
suspension
181-8
181-8+ 15-9
181-8+ 14-4
181-8+ 21-2
174-3± 23-4
In sediment
181-8
129-5+ 17-4
92-4+ 14-4
47-7+ 6-8
14-4+ 4-5
GOT1. The effect of increasing the butan-1-ol
concentration on the GOT activity of the super-
natants obtained from ultrasonically treated
mitochondria was therefore studied. The results in
Table 2 suggest that at a final concentration of 20%
(v/v) butan-l-ol inhibited almost all the activity
of the supernatant.
If butan-l-ol inhibits the GOT activity, then a
decrease in total GOT activity would be expected
when ultrasonically treated mitochondrial suspen-
sions are treated with butan-l-ol. The results in
Table 3 show that this is indeed the case. With
increasing butan- 1 -ol concentration there is a
decrease in the GOT activity of ultrasonically
treated mitochondrial suspension. The decrease in
the GOT activity of the sediment obtained after
centrifugation of butan-1-ol-treated mitochondrial
suspension is apparently due to solubilization of the
pellet enzyme. The supernatant GOT activity
represents the sum of GOT1 that is becoming
inactivated and GOT2 that is becoming solubilized
with increasing concentrations of butan-l-ol.
Column chromatography of liver mitochondrial
GOT. Further confirmation of the existence of two
forms of GOT in mitochondria having different
electrophoretic mobilities, with butan-l-ol specifi-
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Fig. 1. Electrophoretic mobilities of liver mitochondrial
GOT solubilized by ultrasonic treatment and of pellet-
bound GOT solubilized by butan-1-ol. Mitochondria from
I 1g. of liver were suspended in 2ml. of 0-25m-sucrose andIn treated ultrasonically at 15 kcyc./sec. for 1 min., then
supernatant centrifuged at 105OO0g for 1 hr.; the supernatant was
0 spotted for electrophoresis (a) and the pellet was treated
46-2+ 6-8 with 20% (v/v) butan-l-ol and the supernatant spotted for
78-0+ 9-8 electrophoresis (b). The GOT activity in 0-5cm. segments
122-0+ 16-6 ofthe electrophoretograms was measured as described in the
162-9+ 21-9 text. SL, Starting line.
620 1968
TWO FORMS OF ASPARTATE AMINOTRANSFERASE
cally inhibiting one of these, was obtained from
chromatographic studies on CM-cellulose. These
studies showed a difference in elution pattern:
GOT2 was less firnly bound to the column and was
eluted earlier, whereas GOT1 was more firmly held
and eluted later, when the sodium chloride con-
centration was raised (Fig. 2). When the ultra-
sonically treated mitochondrial GOT was treated
with butan-l-ol at a final concentration of 10%
(v/v) and chromatographed, both forms ofGOT were
present, whereas with 20% (v/v) butan-l-ol only
GOT2 was present.
Twoform8 of GOT in rat liver mitochondria. These
results therefore provide further experimental
evidence that there are two forms of GOT in rat
liver mitochondria, and that these, besides differing
in their binding to membrane, have different
electrophoretic, chromatographic and solubility
characteristics.
Table 2. Effect of butan-1-ol concentration on the
GOT activity of the mupernatant obtained by centri-
fugation of ultra8onically treated liver mitochondria
Mitochondria obtained from 1g. of liver were suspended
in 3ml. of 0-25M-sucrose and treated ultrasonically at
15 keyc./sec. for 1 min., then centrifuged at 105 000g for 1 hr.,
and the supernatant was treated with increasing concentra-
tions of butan-l-ol. For further details see the text and
Table 1.
Eichel & Bukovsky (1961) failed to find any
differences in pH optima between readily measur-
able mitochondrial enzyme and that which was
unmasked and solubilized by blending. We also
were unable to find any such differences between
pellet-bound enzyme and the enzyme solubilized
by ultrasonic treatment.
It is relevant to point out that more than one
form of non-mitochondrial GOT has been reported
in cell sap (Decker & Rau, 1963; Martinez-Carrion,
Riva, Turano & Fasella, 1965). A close resemblance
exists between the two GOT enzymes reported in
the present paper and the two glutamate de-
hydrogenases in mitochondria, differing in degree
of attachment and termed tightly and loosely
bound, reported by Hirschberg, Snider & Osnos,
(1964). Two forms ofmalate dehydrogenase in liver
mitochondria have also been reported (Kitto,
Wassarman, Michjeda & Kaplan, 1966). Also,
Wilson (1967) has suggested that the assayable and
latent forms of hexokinase may have different
binding sites in rat brain mitochondria.
Table 4. Intracellular di8tribution of GOT activity
in rat kidney
Perfused rat kidneys were homogenized in 0-25 M-sucrose
and subcellular fractions were isolated by differential
centrifugation. For further details see the text.
Concn. of butan-l-ol
(v/v)
0
5
10
15
20
25
GOT activity in supernatant
-(units)
181-8
163-6+ 15-1
113-6+ 9-8
60-6+ 8-3
15-9+ 6-2
Fraction
Homogenate
Nuclei
Mitochondria
Microsomes
Supernatant
GOT activity
(units/g. fresh wt.
of kidney)
4-90+040
0-35+ 0-06
1-50+ 0-23
0-31 + 0-08
2-65+0-32
Table 3. Effect of butan-I-ol concentration on the GOT activity of ultra8onically treated liver mitochondrial
suspen8ion
Mitochondria obtained from 1g. of liver were suspended in 3 ml. of 0-25 M-sucrose and treated ultrasonically at
15kcyc./sec. for 15min., and the resulting suspension was treated with increasing concentrations of butan-l-ol.
The GOT activity was determined in treated whole suspensions and the sediments and supernatants obtained
after centrifugation at 105 000g for 1 hr. For further details see the text and Table 2.
GOT activity (units)
Conen. of
butan-l-ol
(v/v)
0
5
10
15
20
25
In whole ultrasonically treated
mitochondrial suspension
371-2+ 29-5
319-1 + 23-5
252-3+31 1
197-9+ 23-5
179-5+ 19-7
173-5+ 20-5
In
sediment
181-8+ 15-9
159-1 + 17-4
115-9+ 12-9
67-4+ 12-1
17-4+ 8-3
In
supernatant
194-6+ 20-5
137-1 + 15-9
125-0+ 22-0
144-0+ 15-9
153-8+ 23-5
167-4+22-7
Distribution
(%)
100
7-1
30-7
6-2
53-0
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The previous observation (Bhargava &
Sreenivasan, 1965, 1966a,b) that GOT1 but not
GOT2 is altered in vivo as a result of mitochondrial
damage caused by administration of carbon tetra-
chloride suggests that there are separate control
mechanisms for the two forms; further work will
be needed to establish this.
Intracellular di8tribution of kidney GOT activity.
The results in Table 4 show that 53% of the GOT
activity of kidney homogenate is localized in the
supernatant fraction and that 30% is present in the
1968
mitochondrial fraction. The activity observed in
nuclei and microsomes might be due to contami-
nation with mitochondria.
Solubilization and electrophoretic mobility of
kidney GOT. A severalfold increase in enzyme
activity was observed when kidney mitochondria
were treated with deoxycholate, Triton X-100 or
digitonin or when ultrasonically treated (Fig. 3).
However, maximum activation per mg. of mito-
chondrial protein could be obtained by much less
drastic treatment than that used with liver mito-
chondria (Bhargava & Sreenivasan, 1966a), suggest-
ing that the enzyme in kidney is more loosely
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Fig. 2. Elution patterns of liver mitochondrial GOT
enzymes after various treatments. Mitochondria obtained
from 3g. of liver were suspended in 3 ml. of 0-25M-sucrose
and treated ultrasonically at 15kcyc./min. for 1-5min.,
then centrifuged at 105 000g for 1 hr. A 1 ml. sample of the
supernatant obtained was chromatographed on the CM-
cellulose column (--). The pellet was treated with
butan-l-ol and the supernatant obtained after centrifuga-
tion and dialysis was chromatographed (* *- ). The
ultrasonically treated mitochondrial suspension was also
treated with butan-l-ol at 10% or 20% (v/v) concentration
and the supernatants (------, 10%-butan-1-ol-treated;
- , 20%-butan-1-ol-treated) obtained after centrifuga-
tion and dialysis were chromatographed. Fractions of
volume 3ml. were collected and GOT activity was deter-
mined as described in the text.
0
1.5 r I e I
0 0-5 l-0 l-5 0 0-5 l-0 1-5 2-0
Ultrasonic treatment Deoxycholate (ml.
(sec.) of 0.1%)
4.5
0 30 60 90 0 0-5 1X0 15 2-0
Triton X-100 (ml.
of 0-1%)
Digitonin (ml.
of 0-1%)
Fig. 3. Effect of various treatments on mitochondrial
GOT of rat kidney. Mitochondria obtained from 1g. of
kidney were suspended in 1 ml. of 0-25 M-sucrose and various
treatments were carried out as described in the text.
Table 5. Activation and solubilization of kidney mitochondrial GOT by various treatments
Samples (5 ml.) of 1:20 mitochondrial suspensions were treated as described in Fig. 1 and then centrifuged at
105 000g for 1 hr., and GOT activity was determined in whole mitochondrial suspension, sediment and super-
natant. For further details see the text and Table 1.
GOT activity (units)
Treatment
Nil
Ultrasonic treatment for 90 sec.
Deoxycholate (1-5ml. of 0-1%)
Triton X-100 (I ml. of 0-1%)
Digitonin (I ml. of 0-1%)
In mitochondrial
suspension
1-51+ 0-15
4-16+0-53
4-47+ 0-83
3-56+ 0-53
3-94+ 0-68
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In sediment
1-51 + 0-15
0-37+ 0-22
In supernatant
3-94+ 0-75
4-31+ 0-98
3-49+ 0-45
3-71 + 0-68
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Table 6. Effect of corti8one admini8tration on mitochondrial and 8upernatant GOT enzymes of rat liver
and kidney
A single dose of cortisone was administered intraperitoneally. Rats were killed after 4-6 hr., and the isolation
of mitochondrial and supernatant fractions and determination ofGOT activity were done as described in the text.
GOT activity (units/g. of kidney) GOT activity (units/g. of liver)
Mitochondria Supernatant Mitochondria Supernatant
Control 1-74+ 0-15 2-42 + 0 37 152-3+ 31 1 144-0+ 24-2
Cortisone administered 1-86+ 030 4-47 + 037 2402 + 47-7 267*4+ 38-6
1*50
0(7
^ 4 3 2 I SL I 2 3 4
0
4 3 2 SL 2 3 4
Distance (cm.)
Fig. 4. Electrophoretic mobilities of mitochondrial and
supernatant GOT enzymes of rat kidney. Mitochondria
obtained from 5g. of kidney were suspended in 2ml. of
0 25M-sucrose and ultrasonically treated for about 2min.,
then centrifuged at 1050OOg for 1 hr.; 0.1 ml. was spotted
in the centre of the paper (a). A 02 ml. sample of super-
natant equivalent to 2g. of kidney was also spotted (b).
The measurement of GOT activity in 0-5cm. segments of
the electrophoretograms was carried out as described in the
text. SL, Starting line.
bound. It is, however, also possible that kidney
mitochondria are more easily damaged than those
from liver. When the treated mitochondrial
suspensions, wheremaximum activation is achieved,
were centrifuged at 105 OOOg for 1 hr., all the
activity was recovered in the supernatant (Table 5).
This suggests that the latency observed with kidney
mitochondria is solely due to permeability barriers
and that once the mitochondrial membrane is
broken there is maximum substrate-enzyme
contact and therefore activity. With liver, how-
ever, when the treated mitochondrial suspensions
were centrifuged a certain amount of activity
always remained pellet-bound and could not be
solubilized further by these treatments (Bhargava
& Sreenivasan, 1966b). Thus kidney, unlike liver,
does not have two forms of mitochondrial GOT.
The solubilized kidney mitochondrial enzyme has
cathodic mobility on the paper electrophoretogram,
compared with the anodic mobility of the kidney
supernatant GOT (Fig. 4), as with the liver GOT
enzymes.
Effect of corti8one admini8tration on rat liver and
kidney GOT enzyme8. Cortisone administration
leads to an increase in both the mitochondrial and
the supernatant liver enzymes, but in the kidney
it specifically induces only the supernatant enzyme
under the experimental conditions used (Table 6).
When cortisone is added in vitro to mitochondrial
and supernatant fractions there is no increase in
activity, suggesting that the increased activity
obtained is due not to activation but perhaps to
induction, as has been suggested by Segal, Rosso,
Hopper & Weber, (1962) and Sheid & Roth (1965).
The induction of this enzyme in the supernatant
might explain the increased gluconeogenesis brought
about by cortisone administration (Gavosto,
Pileri & Brusca, 1957; Rosen, Roberts, Budnik &
Nichol, 1958), since (1) all the gluconeogenic
enzymes are localized in this fraction, and (2) the
increased transamination will mean increased
channeling of products of amino acids like oc-oxo-
glutarate and oxaloacetate into the carbon pool
from which glucose is made (Gavosto et al. 1957;
Rosen et al. 1958).
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